StonvexLoading…
StonvexStonvexStonvexCore line items from NMRK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.77B | $2.27B | $2.07B | $2.30B |
Operating Income | $234.00M | $163.04M | $125.22M | $185.57M |
Net Income | $126.19M | $85.49M | $62.38M | $112.55M |
EPS (Diluted) | $0.68 | $0.34 | $0.24 | $0.45 |
Total Assets | $5.02B | $4.71B | $4.47B | $3.94B |
Total Liabilities | $3.27B | $3.17B | $2.88B | $2.40B |
Cash & Equivalents | $229.11M | $197.69M | $164.89M | $233.02M |
Free Cash Flow OCF − CapEx | $142.63M | $-41.45M | $-321.32M | $1.13B |
Shares Outstanding | 253.45M | 177.69M | 176.38M | 245.18M |